Topics

Celyad Announces October and November 2019 Investor Conference Schedule

16:01 EDT 2 Oct 2019 | FinanzNachrichten

Regulatory News: Celyad (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T c...

Original Article: Celyad Announces October and November 2019 Investor Conference Schedule

NEXT ARTICLE

More From BioPortfolio on "Celyad Announces October and November 2019 Investor Conference Schedule"

Quick Search

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...